MedPath

Comparison of the effect of tow embryo transfer in the stage of blastocyst and sequential transfer of a cleavage-a blastocyst embryo on pregnancy outcomes Patients who are candidates for frozen embryo transfer and recurrent implantation failure; a randomized clinical trial

Phase 3
Recruiting
Conditions
Infertility.
Female infertility
Registration Number
IRCT20110509006420N27
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
140
Inclusion Criteria

Candidates for frozen embryo transfer
Failure of more than 2 implants
The number of frozen embryos is at least four
Women under the age of 45

Exclusion Criteria

Uncontrolled endocrine diseases (diabetes, hyperthyroid and hypothyroid)
Egg donation
Uncontrolled autoimmune diseases (lupus and rheumatoid arthritis)
Severe uterine adenomyosis
Sever Asherman
Untreated hydrosalpinx

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Through the measurement of BHCG.;Twin pregnancy. Timepoint: In the 6th week of pregnancy. Method of measurement: Observation of two gestational sacs in vaginal ultrasound.;The rate of premature abortion. Timepoint: Ten weeks after embryo transfer. Method of measurement: Absence of fetal heartbeat in sonography.;Ectopic pregnancy. Timepoint: After proving chemical pregnancy. Method of measurement: Not increasing beta hCG titer and not seeing pregnancy sac in vaginal ultrasound.
© Copyright 2025. All Rights Reserved by MedPath